ALLMedicine™ Fibrolamellar Carcinoma Center
Research & Reviews 109 results
https://doi.org/10.1016/j.ejca.2020.06.035
European Journal of Cancer (Oxford, England : 1990); Lamarca A, Frizziero M et. al.
Aug 9th, 2020 - Fibrolamellar carcinoma (FLC) is a rare and poorly understood malignancy, which seems to be more prevalent in young patients compared with conventional hepatocellular carcinoma (HCC). Performing prospective clinical trials recruiting patients diag...
https://doi.org/10.1002/cncr.32960
Cancer References; El Dika I, Bowman AS et. al.
Jul 14th, 2020 - Fibrolamellar carcinoma (FLC) is a rare primary liver cancer of young adults. A functional chimeric transcript resulting from the in-frame fusion of the DNAJ homolog, subfamily B, member 1 (DNAJB1), and the catalytic subunit of protein kinase A (P...
https://doi.org/10.1177/1066896920933344
International Journal of Surgical Pathology; du Toit M, Aldera AP
Jun 6th, 2020 - Biopsies of liver mass lesions are encountered frequently in general surgical pathology practice. The clinical differential diagnosis is typically hepatocellular carcinoma (HCC) versus metastatic adenocarcinoma. There are a variety of HCC variants...
https://doi.org/10.1016/j.mayocp.2020.04.024
Mayo Clinic Proceedings; Erickson LA
Jun 5th, 2020 - Fibrolamellar Carcinoma.|2020|Erickson LA,|
https://doi.org/10.1634/theoncologist.2020-0367
The Oncologist References; El Dika I, Mayer RJ et. al.
May 13th, 2020 - FLC is a complex cancer with many implicated oncogenic pathways. Single or dual targeting does not appear to alter the natural history of the cancer, and novel therapeutics are needed. Estrogen deprivation therapy with letrozole and leuprolide, al...
Clinicaltrials.gov 109 results
https://doi.org/10.1016/j.ejca.2020.06.035
European Journal of Cancer (Oxford, England : 1990); Lamarca A, Frizziero M et. al.
Aug 9th, 2020 - Fibrolamellar carcinoma (FLC) is a rare and poorly understood malignancy, which seems to be more prevalent in young patients compared with conventional hepatocellular carcinoma (HCC). Performing prospective clinical trials recruiting patients diag...
https://doi.org/10.1002/cncr.32960
Cancer References; El Dika I, Bowman AS et. al.
Jul 14th, 2020 - Fibrolamellar carcinoma (FLC) is a rare primary liver cancer of young adults. A functional chimeric transcript resulting from the in-frame fusion of the DNAJ homolog, subfamily B, member 1 (DNAJB1), and the catalytic subunit of protein kinase A (P...
https://doi.org/10.1177/1066896920933344
International Journal of Surgical Pathology; du Toit M, Aldera AP
Jun 6th, 2020 - Biopsies of liver mass lesions are encountered frequently in general surgical pathology practice. The clinical differential diagnosis is typically hepatocellular carcinoma (HCC) versus metastatic adenocarcinoma. There are a variety of HCC variants...
https://doi.org/10.1016/j.mayocp.2020.04.024
Mayo Clinic Proceedings; Erickson LA
Jun 5th, 2020 - Fibrolamellar Carcinoma.|2020|Erickson LA,|
https://doi.org/10.1634/theoncologist.2020-0367
The Oncologist References; El Dika I, Mayer RJ et. al.
May 13th, 2020 - FLC is a complex cancer with many implicated oncogenic pathways. Single or dual targeting does not appear to alter the natural history of the cancer, and novel therapeutics are needed. Estrogen deprivation therapy with letrozole and leuprolide, al...
News 1 results
https://www.mdedge.com/gihepnews/article/198920/liver-disease/microrna-375-may-be-key-fibrolamellar-carcinoma?channel=69
Will Pass, MDedge News
Apr 15th, 2019 - Up-regulation of microRNA-375 may be a future therapeutic strategy for patients with fibrolamellar carcinoma (FLC), according to investigators. Analysis of primary FLC tumors showed that microRNA-375 was the most abnormal microRNA, down-regulated.
